Piper Sandler initiates coverage on Thermo Fisher with Neutral rating
Piper Sandler analyst David Westenberg initiates coverage on Thermo Fisher Scientific with a Neutral rating and a price target of $510.
*this image is generated using AI for illustrative purposes only.
Piper Sandler analyst David Westenberg has initiated coverage on Thermo Fisher Scientific with a Neutral rating and a price target of $510. The rating provides a benchmark for the stock's performance potential relative to its current trading levels.
Coverage Details
The initiation by Piper Sandler offers investors a new perspective on Thermo Fisher Scientific's market position. The Neutral rating suggests that the stock is expected to perform in line with the broader market or industry averages over the specified period.
| Analyst | Firm | Rating | Price Target |
|---|---|---|---|
| David Westenberg | Piper Sandler | Neutral | $510 |
The price target of $510 serves as a key indicator of the firm's valuation expectations for the company. Investors will likely monitor the stock's movement relative to this target in the coming sessions.
What factors could drive Thermo Fisher Scientific to outperform the Neutral rating?
How might recent market trends impact the company's ability to reach the $510 price target?
What are the key risks Piper Sandler identified that could limit upside potential?
19
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
